Highly energetic pyrophosphate bonds are a fundamental component of several higher inositol polyphosphates, including diphosphoinositol pentakisphosphate (InsP7) and bis-diphosphoinositol tetrakisphosphate (InsP8) 1,2 . InsP7 arises from pyrophosphorylation of inositol hexakisphosphate (InsP6; phytic acid), one of the most abundant inositol phosphates in mammalian cells. The enzymes that catalyze the synthesis of InsP7 from InsP6 constitute a family of inositol hexakisphosphate kinases (InsP6Ks) that includes InsP6K1, InsP6K2 and InsP6K3 (refs. 3, 4) . InsP7 and InsP8 are dynamic molecules with very rapid turnover rates [5] [6] [7] . In mammalian cells, InsP7 has been linked to several cellular functions, including vesicular trafficking and exocytosis 8, 9 , apoptosis 10-13 and insulin disposition 14 . InsP7 is a physiological inhibitor of Akt, a serine-threonine kinase that regulates glucose homeostasis by inhibiting the nuclear kinase GSK3β 15 . InsP7 affects this pathway by potently inhibiting phosphorylation of Akt by the phosphoinositide-dependent protein kinase PDK1, preventing Akt activation and thereby affecting insulin signaling. In mice with targeted deletion of InsP6K1, Akt signaling is much greater and GSK3β signaling is much lower in skeletal muscle, white adipose tissue and liver. As a result, InsP6K1-deficient mice manifest insulin sensitivity and are resistant to obesity elicited by a high-fat diet or aging 15 .
A r t i c l e s
Highly energetic pyrophosphate bonds are a fundamental component of several higher inositol polyphosphates, including diphosphoinositol pentakisphosphate (InsP7) and bis-diphosphoinositol tetrakisphosphate (InsP8) 1, 2 . InsP7 arises from pyrophosphorylation of inositol hexakisphosphate (InsP6; phytic acid), one of the most abundant inositol phosphates in mammalian cells. The enzymes that catalyze the synthesis of InsP7 from InsP6 constitute a family of inositol hexakisphosphate kinases (InsP6Ks) that includes InsP6K1, InsP6K2 and InsP6K3 (refs. 3,4) . InsP7 and InsP8 are dynamic molecules with very rapid turnover rates [5] [6] [7] . In mammalian cells, InsP7 has been linked to several cellular functions, including vesicular trafficking and exocytosis 8, 9 , apoptosis [10] [11] [12] [13] and insulin disposition 14 . InsP7 is a physiological inhibitor of Akt, a serine-threonine kinase that regulates glucose homeostasis by inhibiting the nuclear kinase GSK3β 15 . InsP7 affects this pathway by potently inhibiting phosphorylation of Akt by the phosphoinositide-dependent protein kinase PDK1, preventing Akt activation and thereby affecting insulin signaling. In mice with targeted deletion of InsP6K1, Akt signaling is much greater and GSK3β signaling is much lower in skeletal muscle, white adipose tissue and liver. As a result, InsP6K1-deficient mice manifest insulin sensitivity and are resistant to obesity elicited by a high-fat diet or aging 15 .
Although it is well documented that InsP7 can regulate a variety of cellular processes, its physiological importance and the underlying molecular mechanism are unclear. In Dictyostelium discoideum, InsP7 competes with phosphatidylinositol-(3,4,5)-trisphosphate (PtdIns(3,4,5)P 3 ) for binding pleckstrin homology (PH) domains and negatively regulates PtdIns(3,4,5)P 3 signaling 16 . In these cells, chemoattractant stimulation triggers the membrane translocation of many PH domain-containing proteins via specific binding to PtdIns(3,4,5)P 3 , which induces actin polymerization and chemotactic migration [17] [18] [19] . Depletion of InsP7 by deletion of the gene encoding InsP6K (Ip6k1) enhances membrane translocation of PH domain-containing proteins and augments downstream chemotactic signaling. Such translocation was previously thought to be dependent solely on the concentration of PtdIns(3,4,5)P 3 in the membrane 20 . Thus, these findings not only established a fundamental role for InsP7 in cellular signal-transduction pathways but also described a previously unknown mode of regulation for the function of the PH domain; that is, the relative concentrations of InsP7 and PtdIns(3,4,5)P 3 . Here we further assessed the role of InsP6K1 in neutrophils. We found that InsP7, by blocking PtdIns(3,4,5)P 3 -mediated plasma membrane translocation of PH domain-containing proteins, negatively regulated several PtdIns(3,4,5)P 3 -mediated neutrophil Inositol phosphates are widely produced throughout animal and plant tissues. Diphosphoinositol pentakisphosphate (InsP7) contains an energetic pyrophosphate bond. Here we demonstrate that disruption of inositol hexakisphosphate kinase 1 (InsP6K1), one of the three mammalian inositol hexakisphosphate kinases (InsP6Ks) that convert inositol hexakisphosphate (InsP6) to InsP7, conferred enhanced phosphatidylinositol-(3,4,5)-trisphosphate (PtdIns(3,4,5)P 3 )-mediated membrane translocation of the pleckstrin homology domain of the kinase Akt and thus augmented downstream PtdIns(3,4,5)P 3 signaling in mouse neutrophils. Consequently, these neutrophils had greater phagocytic and bactericidal ability and amplified NADPH oxidase-mediated production of superoxide. These phenotypes were replicated in human primary neutrophils with pharmacologically inhibited InsP6Ks. In contrast, an increase in intracellular InsP7 blocked chemoattractant-elicited translocation of the pleckstrin homology domain to the membrane and substantially suppressed PtdIns(3,4,5)P 3 -mediated cellular events in neutrophils. Our findings establish a role for InsP7 in signal transduction and provide a mechanism for modulating PtdIns(3,4,5)P 3 signaling in neutrophils.
A r t i c l e s functions, including NADPH oxidase-mediated superoxide production, phagocytosis and bacterial killing. Our findings establish InsP6K1 as a physiological negative regulator in neutrophils and suggest that therapeutic interventions targeting InsP6K1 may be a promising approach to modulating neutrophil responses in infectious and inflammatory diseases.
RESULTS
InsP6K1 disruption augments PtdIns(3,4,5)P 3 signaling To study the cellular function of inositol pyrophosphate in neutrophils, we first determined which InsP6K isoforms are expressed in these cells. RT-PCR analysis showed expression of InsP6K1 and InsP6K2, but not InsP6K3, in neutrophils (Fig. 1a) . Mice with homozygous deficiency of the gene encoding InsP6K1 (Ip6k1 −/− mice) are viable and do not show any gross physical or behavioral abnormalities 14 . We characterized the hematopoietic cells in these mice and found that their peripheral blood count was normal. Microscopic examination of blood smears did not show any morphological abnormality in Ip6k1 −/− neutrophils (data not shown). We confirmed the depletion of InsP6K1 protein and mRNA in neutrophils by immunoblot analysis and RT-PCR, respectively (Fig. 1a,b) .
InsP7 inhibits binding of the PtdIns(3,4,5)P 3 PH domain 16 . In D. discoideum, depletion of InsP7 by deletion of the gene encoding InsP6K enhances membrane translocation of the PH domain and augments downstream chemotactic signaling 16 . To address whether mammalian InsP6K1 and its product InsP7 regulate PtdIns(3,4,5)P 3 signaling in neutrophils, we first measured the activation of endogenous Akt by assessing the degree of Akt phosphorylation 21 ( Fig. 1c) . Before chemoattractant stimulation, Akt phosphorylation was almost completely undetectable in both wild-type and Ip6k1 −/− neutrophils. We found much more Akt phosphorylation in response to formyl-Met-Leu-Phe (fMLP), a tripeptide widely used as a model chemoattractant in studies of neutrophil function; it was significantly greater in Ip6k1 −/− neutrophils than in wild-type neutrophils at every time point, whereas the time course for the increase was not altered in Ip6k1 −/− neutrophils (Fig. 1d) .
To further assess the effect of InsP6K1 depletion on fMLP-elicited PtdIns(3,4,5)P 3 signaling, we directly measured chemoattractantelicited translocation of the PH domain (Fig. 1e) by using the PH domain of Akt (PH Akt ) fused with green fluorescent protein (PH Akt -GFP) as a marker 22 . During uniform treatment with chemoattractant, PH Akt -GFP transiently translocates from cytosol to the plasma membrane 23 . Membrane translocation of PH Akt -GFP occurred instantaneously and peaked within 10-20 s at a saturating concentration of fMLP (100 nM). The amount of membrane-associated PH Akt -GFP was significantly greater in Ip6k1 −/− neutrophils than in wild-type neutrophils (Fig. 1f) . The InsP6K1 disruption-induced increase in membrane translocation of Akt was dependent on PtdIns(3,4,5)P 3 production, as the phosphatidylinositol-3-OH kinase (PI(3)K) inhibitors wortmannin and LY294002 completely abolished the translocation of Akt (Supplementary Fig. 1a ) and the subsequent activation of Ip6k1 −/− neutrophils (Supplementary Fig. 1b) . In addition, this cellular process also depended on direct binding of PH Akt to PtdIns(3,4,5)P 3 . Two PH Akt mutants without the ability to bind PtdIns(3,4,5)P 3 , PH Akt (R25C) and PH Akt (K14R) 24 , failed to respond to chemoattractant stimulation even in Ip6k1 −/− neutrophils (Supplementary Fig. 2 ). The effect of InsP6K1 disruption on PtdIns(3,4,5)P 3 signaling seemed to be specific. Receptor expression ( Supplementary Fig. 3a) , phosphorylation of several other kinases, such as Erk and p38 ( Supplementary Fig. 3b ), calcium mobilization ( Supplementary Fig. 3c ) and sensitivity to chemoattractant stimulation ( Supplementary Fig. 4a and Supplementary Movies 1 and 2) were unaltered in Ip6k1 −/− neutrophils. Collectively, these results indicate that InsP6K1 and its product InsP7 are specific negative regulators of PtdIns(3,4,5)P 3 signaling in neutrophils.
Enhanced superoxide production in Ip6k1 −/− neutrophils One important downstream effect of chemoattractant-induced production of PtdIns(3,4,5)P 3 in neutrophils is NADPH oxidase-mediated production of superoxide [25] [26] [27] [28] [29] [30] [31] . Consistent with their augmented PtdIns(3,4,5)P 3 signaling, Ip6k1 −/− neutrophils showed significantly enhanced NADPH oxidase activation, as assessed by isoluminol chemiluminescence assay (Fig. 2a,b) . After treatment with phorbol-12-myristate-13-acetate (PMA), an activator of protein kinase C, Ip6k1 −/− neutrophils generated almost the same amount of superoxide as wild-type neutrophils did (Fig. 2a,b) , which suggested that the enhanced superoxide production in Ip6k1 −/− neutrophils was specific for receptor-mediated signals. In addition, a cytochrome c-reduction assay showed that total production of reactive oxygen species (ROS) was much greater in Ip6k1 −/− neutrophils than in wild-type I n s P 6 K 1 I n s P 6 K 2 I n s P A r t i c l e s neutrophils (Fig. 2c) . Isoluminol is a membrane-impermeable reagent and thus can detect only ROS released to the extracellular space by oxidase on the plasma membrane. To determine whether InsP6K1 also regulates NADPH oxidase on intracellular granules, endosomes and lysosomes, we used membrane-permeable luminol, which in the presence of catalase and superoxide dismutase measures only ROS production by intracellular NADPH oxidase. Under these conditions, we observed much more ROS production in Ip6k1 −/− neutrophils than in in wild-type neutrophils (Fig. 2d) . The InsP6K1 disruptioninduced increase in ROS production was abolished in neutrophils treated with wortmannin or LY294002 (Supplementary Fig. 5a ). Chemoattractant-elicited ROS production is mediated mainly by G protein-coupled receptors and PI(3)Kγ. The PI(3)Kγ-specific inhibitor AS-252424 inhibited ROS production in both wild-type and Ip6k1 −/− neutrophils ( Supplementary Fig. 5a ), whereas the Aktspecific inhibitor Akt inhibitor VIII only partially suppressed ROS production but completely abrogated the enhancing effect on ROS production that resulted from InsP6K1 disruption ( Supplementary  Fig. 5a ). These results suggest that Akt may not be the only mediator of chemoattractant-elicited ROS production, but it is a key downstream target of InsP6K1. Thus, by regulating PtdIns(3,4,5)P 3 signaling, InsP6K1 acts as a key regulator of superoxide production in mouse neutrophils.
InsP6K inhibition in human neutrophils
We next determined whether inhibition of InsP6K enhances PtdIns(3,4,5)P 3 signaling in human primary neutrophils. TNP (N(2)-(m-(trifluoromethy)lbenzyl) N(6)-(p-nitrobenzyl)purine) is a selective inhibitor of InsP6K activity in vitro and inhibits the synthesis of InsP7 and InsP8 in vivo without affecting the amount of other inositol phosphates or the activity of a large number of protein kinases 32 . Human neutrophils treated with TNP showed significantly enhanced fMLPelicited phosphorylation of Akt ( Fig. 3a) , which indicated that InsP6K1 negatively regulates PtdIns(3,4,5)P 3 signaling in human neutrophils. 
A r t i c l e s
Consequently, both intracellular and extracellular NADPH oxidasemediated production of superoxide were significantly greater in human neutrophils treated with TNP (Fig. 3b,c) . A distinct chemoattractant, complement fragment C5a, also induced enhanced production of ROS in TNP-treated neutrophils relative to that in control cells (Fig. 3d,e) . Similar to results obtained with mouse neutrophils, the augmented ROS production in InsP6K1-disrupted human neutrophils was dependent on PtdIns(3,4,5)P 3 generation and Akt activation ( Supplementary  Fig. 5a ). Disruption of InsP6K1 did not directly alter the amount of PtdIns(3,4,5)P 3 in either unstimulated or fMLP-stimulated neutrophils (Fig. 4) . These results suggest that InsP6K also has a role in regulating PtdIns(3,4,5)P 3 -mediated membrane translocation of PH domaincontaining proteins in human neutrophils.
InsP6K overexpression suppresses PtdIns(3,4,5)P 3 signaling To investigate whether increasing expression of the gene encoding InsP6K1 and the amount of cellular InsP7 can suppress PtdIns(3,4,5)P 3 signaling, we used neutrophil-like differentiated HL60 human promyelocytic leukemia cells (dHL60 cells), in which specific genes can be easily overexpressed (Supplementary Fig. 6 ). We labeled endogenous stores of inositol phosphate with 3 H-labeled inositol and measured inositol phosphates by high-performance liquid chromatography. We detected much more InsP7 in HL60 cells overexpressing InsP6K1, whereas a control construct or a 'kinase-dead' mutant of InsP6K1 had no effect (Fig. 5a,b) . Akt phosphorylation was greater in dHL60 cells stimulated with fMLP (Fig. 5c) ; this was significantly suppressed in cells overexpressing InsP6K1 but not in those overexpressing the 'kinase-dead' InsP6K1 mutant, which indicates that the InsP6K1-mediated conversion of InsP6 to InsP7 is essential for the suppression of PtdIns(3,4,5)P 3 signaling. In addition, overexpression of InsP6K1 in dHL60 cells resulted in less membrane translocation of PH Akt -GFP than in control cells (Fig. 5d,e) . As a result, NADPH oxidase-mediated production of ROS decreased in dHL60 cells overexpressing InsP6K1 (Fig. 5f) . The suppression of ROS production depended on the kinase activity of InsP6K, because the overexpression of the 'kinase-dead' InsP6K1 mutant failed to elicit the same effect (Fig. 5f) . Overexpression of InsP6K2 and InsP6K3 resulted in more InsP7 in dHL60 cells as well and consequently suppressed PtdIns(3,4,5)P 3 signaling in these cells (Fig. 5) . InsP7, the product of InsP6K1, directly binds PH Akt and consequently inhibits binding of the PtdIns(3,4,5)P 3 PH domain 16 .
Together with the inability of the 'kinase-dead' InsP6K1 mutant to suppress PtdIns(3,4,5)P 3 signaling in dHL60 cells, these observations indicate that the inhibitory effect of InsP6K1 on PtdIns(3,4,5)P 3 signaling and the NADPH oxidase-mediated oxidative burst are mediated by its metabolic product, InsP7.
InsP7 inhibits superoxide production in a cell-free system Given that InsP7 is a highly hydrophilic molecule and cannot passively cross the plasma membrane, the intracellular concentration A r t i c l e s of InsP7 cannot be increased by the addition of InsP7 to the culture medium. To circumvent this prohibitive property of InsP7 and assess its intracellular functions directly, we took advantage of an established cell-free system for the activation of NADPH oxidase 33 that reconstitutes intracellular NADPH oxidase activity in neutrophils made permeable by streptolysin-O. Pore formation by streptolysin-O is restricted to the plasma membrane and keeps intracellular membranes intact. Thus, this system faithfully recapitulates the assembly of the NADPH oxidase in intracellular compartments. Polymorphonuclear neutrophils made permeable by streptolysin-O and depleted of cytosol were reconstituted by the addition of cytosol, NADPH, ATP, PMA and GTPγS, which activates the G protein-coupled receptor in the absence of receptor activation. Similar to NADPH oxidase-mediated production of ROS by intact neutrophils, reconstitution of NADPH oxidase in this ex vivo system depended upon G protein-coupled receptors and PI(3)K activity, because wortmannin considerably suppressed the GTPγS-induced production of ROS (Fig. 6a) . The addition of exogenous InsP7 to the reaction resulted in less ROS production, whereas InsP6 and inositol hexakissulfate were essentially ineffective (Fig. 6b) . Collectively, these results demonstrate that InsP7 directly inhibits PtdIns(3,4,5)P 3 signaling and NADPH oxidase activity in neutrophils.
Less InsP7 in neutrophils stimulated with chemoattractants
The concentrations of intracellular signaling molecules are often tightly regulated; thus, we explored whether chemoattractant stimulation altered the amount of endogenous InsP7 in dHL60 neutrophils. These cells had substantial expression of InsP7 (Fig. 7a) . Exposure to fMLP induced a pronounced and rapid decrease in InsP7 of more than 80% within 1 min of fMLP stimulation (Fig. 7b) . The degree of downregulation induced by fMLP was similar to that induced by the InsP6K inhibitor TNP (Fig. 7c) . These results indicate that more than half the original amount of InsP7 was still present in the cells at the time of peak membrane translocation of PH Akt , which happened at about 30 s after stimulation (Figs. 5e and 7b) . These observations suggest that InsP7 may represent a mechanism for controlling optimal Akt activation. The large amount of InsP7 in unstimulated dHL60 cells may be important for preventing neutrophil hyperactivation, whereas the decrease in InsP7 after stimulation with chemoattractants may be necessary to allow sustained Akt signaling in stimulated cells.
Augmented bacterial killing in Ip6k1 −/− mice Next we used a mouse model of acute peritoneal inflammation (peritonitis) 22, 34 to examine neutrophil-mediated killing of bacteria in Ip6k1 −/− mice in vivo. We challenged mice by intraperitoneal injection of Escherichia coli. We detected significantly more ROS in the peritoneal lavage fluid of Ip6k1 −/− mice than in that of wild-type mice (Fig. 8a) . To assess the ability of neutrophils to kill bacteria after bacterial challenge, we explored the survival rate of intraperitoneally injected live E. coli (Fig. 8b,c) . Because of cell proliferation, the number of bacteria gradually increased after the initial injection. When a substantial number of neutrophils accumulated in the peritoneal cavity (4 h after the injection), the number of bacteria stopped increasing and began to decrease, reflecting the bacteria-killing ability of neutrophils (data not shown). We detected fewer bacteria in inflamed Ip6k1 −/− mice (Fig. 8c) , which suggested enhanced bacteria-killing ability. We obtained similar results with a peritonitis model and another bacterial pathogen, Staphylococcus aureus (Fig. 8d,e) . To eliminate the possibility of any effect caused by recruitment of neutrophils, we normalized the number of live bacteria to the amount of neutrophils recruited to the inflamed peritoneal cavity (Fig. 8c,e) . Because we assessed live bacteria at a relatively early stage of the infection (4 h after bacteria injection), before the recruitment of inflammatory macrophages and lymphocytes, the greater bacteria-killing ability observed in Ip6k1 −/− mice most probably resulted from the enhanced PtdIns(3,4,5)P 3 signaling in Ip6k1 −/− neutrophils.
InsP6K1 does not regulate neutrophil trafficking and survival
Neutrophil accumulation at inflammatory sites is an essential component of innate immunity and is required for the host's ability to kill invading pathogens. In the peritonitis model described above, we a b Fig. 7 ). This may have been due to the fast clearance of bacteria and accelerated resolution of inflammation in these mice. Alternatively, it could have been the result of the larger amount of ROS in the peritoneal cavity, which can induce the deactivation of proinflammatory chemokines such as C5a, fMLP 35 A r t i c l e s to further augment cell adhesion, directionality and migration speed in mouse neutrophils ( Supplementary Fig. 8 and Supplementary  Movies 3-6 ). In addition, in an in vivo adoptive transfer assay, we detected similar recruitment of Ip6k1 −/− neutrophils and wild-type neutrophils to the inflamed peritoneal cavity (Supplementary Fig. 9 ).
Finally, neutrophil accumulation could be the result of accelerated neutrophil death. However, we examined the spontaneous death of neutrophils by in vitro assay and found no substantial difference between wild-type and Ip6k1 −/− neutrophils (Supplementary Fig. 10) .
Together these results demonstrate that the attenuated peritoneal accumulation of neutrophils and enhanced bacteria-killing ability of Ip6k1 −/− mice were not due to altered neutrophil recruitment.
Enhanced phagocytosis in Ip6k1 −/− neutrophils To address wither deletion of InsP6K1 enhances the intrinsic bacteriakilling ability of neutrophils, we did an in vitro bacteria-killing assay with purified wild-type and Ip6k1 −/− neutrophils. The ability of Ip6k1 −/− neutrophils to kill E. coli was 140% greater at 30 min after infection and 125% greater at 1 h after infection relative to that of wildtype neutrophils (Fig. 9a) . We obtained similar results with cells incubated with S. aureus (Fig. 9b) . Because the enhanced killing of bacteria could have been due to enhanced superoxide production in the phagosomes, we investigated whether deletion of InsP6K1, in addition to augmenting chemoattractant-elicited production of ROS, influenced phagocytosis-induced generation of ROS. Ip6k1 −/− neutrophils were 100% and 80% more efficient than wild-type neutrophils in phagocytosis-associated production of ROS in response to zymosan and E. coli stimulation, respectively (Fig. 9c) . We obtained similar results with dHL60 cells treated with the InsP6K inhibitor TNP (Fig. 9d) .
We further investigated the intracellular bactericidal activity of Ip6k1 −/− neutrophils by a gentamicin-protection assay. Gentamicin cannot penetrate eukaryotic cells and thus cannot kill internalized intracellular bacteria. We quantified viable intracellular bacteria by subsequent plating of lysed samples onto agar plates. Consistent with their greater production of superoxide in the phagosome, Ip6k1 −/− neutrophils killed engulfed bacteria more efficiently than wild-type neutrophils did (Fig. 9e) .
Augmented phagocytosis might also explain the enhanced killing of bacteria observed in Ip6k1 −/− mice. To test this, we quantified zymosan (Saccharomyces cerevisiae) bioparticles engulfed by each mouse neutrophil by an in vitro phagocytosis assay (Fig. 9f) . The phagocytic index of wild-type neutrophils was 47, which meant that an average of 47 mouse serum-opsonized fluorescein-conjugated zymosan particles were engulfed by 100 neutrophils after 1 h incubation at 37 °C. Ip6k1 −/− neutrophils had an average phagocytic index of 100 (Fig. 9g) . We detected a similar effect in in vitro phagocytosis assays using bacteria bioparticles. The phagocytosis index of Ip6k1 −/− neutrophils was 120% higher than that of wild-type neutrophils (Fig. 9g) . The augmented phagocytosis was probably the result of enhanced engulfment, because there was no difference between wild-type and Ip6k1 −/− neutrophils in the initial binding to zymosan or E. coli particles (Fig. 9h) . Together these findings demonstrate that augmenting PtdIns(3,4,5)P 3 signaling by InsP6K1 disruption leads to enhanced phagocytosis and antimicrobial defense in InsP6K1-deficient mice.
DISCUSSION
Here we reported that InsP7, which is synthesized by InsP6K, competed with PH Akt for binding to PtdIns(3,4,5)P 3 and thus negatively regulated PtdIns(3,4,5)P 3 -mediated cellular functions in neutrophils. Disruption of the gene encoding InsP6K1, one of the three mammalian InsP6Ks that convert InsP6 to InsP7, resulted in enhanced PtdIns(3,4,5)P 3 signaling in mouse neutrophils. Ip6k1 −/− neutrophils had greater phagocytic and bactericidal ability as well as amplified NADPH oxidase-mediated production of superoxide.
InsP7 contains a high-energy pyrophosphate and has been linked to a variety of cellular activities, but its signaling pathways have remained obscure. Our observation that InsP7 was a physiological regulator of the interaction between PH Akt and PtdIns(3,4,5)P 3 may be indicative of a general phenomenon. InsP7 functions as a PtdIns(3,4,5)P 3 -binding competitor for several other PH domain-containing proteins, such as PIKE and Tiam 16 . InsP7 can also bind to and regulate the function of proteins without a PH domain. InsP7 directly binds the cytosolic complex of cyclin-dependent kinase and its inhibitor, required for phosphate homeostasis in yeast 41 . Additionally, it binds to clathrinassociated proteins such as AP2 and AP180 (refs. 42,43) . Binding of InsP7 to AP180 negatively regulates clathrin cage-assembly activity 43, 44 . InsP7 can also serve as a phosphate donor, in a nonenzymatic way 45, 46 . Inositol pyrophosphates can transfer their highenergy β-phosphate moiety only to pre-phosphorylated serine residues to generate pyrophosphoserine 45, 46 . InsP7-mediated protein phosphorylation occurs predominantly at a region containing extensive stretches of serine residues surrounded by acidic amino acids 45, 46 . Such a sequence is not present in Akt, which does not seem to be a target protein 45, 46 . Thus, pyrophosphorylation is probably not involved in the regulation of Akt by InsP7.
Activation of neutrophils at inflammatory sites is an essential component of the innate immune response. However, hyperactivation of neutrophils can also damage surrounding tissues through the release of toxic ROS and granule enzymes such as proteases, causing acute inflammation. Thus, neutrophil activity needs to be carefully controlled by both positive and negative regulators. InsP7 has become a putative candidate for such homeostatic regulation. The amount of InsP7 is tightly regulated in neutrophils. There was substantial InsP7 in unstimulated cells, which prevented neutrophil hyperactivation and ensured optimal cellular inflammatory response. The cellular concentration of InsP7 rapidly decreased after stimulation with chemoattractants, which allowed the induction of sustained PtdIns(3,4,5)P 3 signals in responding neutrophils. InsP7 negatively regulates Akt signaling in glucose homeostasis and protein translation 15 but, unlike our results here, in which chemoattractants inhibited InsP7 formation, growth factors stimulate the generation of InsP7. Therefore, although the inhibition of Akt signaling by InsP7 may be a general phenomenon in cellular signal transduction, the mechanism of its regulation as well as the resulting physiological consequences can be considerably different in different cell systems. At present, the mechanisms by which InsP7 production is suppressed in chemoattractant-stimulated neutrophils are largely unknown. This probably involves activation of inositol pyrophosphate phosphatase and/or deactivation of InsP6K.
PtdIns(3,4,5)P 3 signaling has been linked to several cellular processes related to neutrophil trafficking, particularly adhesion and chemotactic migration 18, [38] [39] [40] . Similar results have also been reported for other cell types, such as mast cells, in which PI(3)K pathway has an important role in integrin-mediated cell adhesion and migration 47 . Nevertheless, we found that disruption of InsP6K1 failed to further augment cell adhesion, directionality or migration speed in neutrophils. Our results are somewhat different from the migration phenotypes of neutrophils deficient in the inositol phosphatase PTEN, which also show markedly enhanced PtdIns(3,4,5)P 3 signaling 21 . Although the overall chemotactic migration of PTENdeficient neutrophils is relatively normal, PTEN disruption results in mildly impaired directionality, enhanced sensitivity to chemoattractant stimulation and slightly greater migration speed 21 .
A r t i c l e s
The distinct effects are probably caused by differences in the temporal and spatial regulation of PTEN and InsP6K1 in neutrophils. PTEN activity is increased and its subcellular localization is altered after chemoattractant stimulation 48 . In contrast, InsP7 was abundant in unstimulated neutrophils and was much lower in abundance after stimulation with chemoattractants. In addition, the mechanisms by which PTEN and InsP6K1 regulate PtdIns(3,4,5)P 3 signaling are different. PTEN regulates the amount of PtdIns(3,4,5)P 3 and controls neutrophil function via several downstream pathways. In contrast, deletion of InsP6K1 did not alter the amount of PtdIns(3,4,5)P 3 in the cell, and its effect was limited to inhibition of Akt.
Although the increased PtdIns(3,4,5)P 3 signaling after Ip6k1 deletion directly improved the phagocytic and bactericidal ability of neutrophils, we cannot completely rule out the possibility that other cell types, such as macrophages, also accounted for the improved bacterial killing in the peritoneum of Ip6k1 −/− mice. The enhanced bacterial killing in the Ip6k1 −/− mice was associated with attenuated peritoneal accumulation of neutrophils. It is unlikely that this effect was caused by accelerated neutrophil death, because we assessed the neutrophils at 4 h after the induction of peritonitis, when neutrophil death had not yet occurred. We also directly examined the spontaneous death of neutrophils by in vitro assay and found no substantial difference between wild-type and Ip6k1 −/− neutrophils. Additionally, by adoptive-transfer assay, we showed that disruption of InsP6K1 did not affect the migration of neutrophils to sites of inflammation. Thus, the lower accumulation of neutrophils was probably an outcome of augmented bacterial clearance and accelerated resolution of inflammation. Alternatively, it could have been due to the higher concentration of ROS in the inflamed peritoneal cavity of Ip6k1 −/− mice. ROS are able to deactivate proinflammatory chemokines such as C5a, fMLP 35 , LTB4 (ref. 36 ) and interleukin 8 (ref. 37) , which leads to less recruitment of neutrophils.
Our findings have indicated that inositol phosphates that contain more phosphate groups are important in a variety of cellular functions and can regulate signal transduction in a ubiquitous way akin to that of other welldescribed signaling effectors, such as kinases and phosphatases. The fairly ubiquitous expression of InsP6K1 suggests that it may also regulate other blood cells, such as lymphocytes and macrophages. These findings suggest that InsP6K1 and its phosphorylation product InsP7 may be promising therapeutic targets for modulating functions of cells of the immune response in various infectious and inflammatory diseases.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
